Dandex

Neumirna Therapeutics ApS

Active

CVR 41696451 · Anpartsselskab · Forskning og eksperimentel udvikling inden for naturvidenskab og teknik

Founded 21 September 2020

5

Employees (2024)

-5.5M

Gross Profit (DKK)

-8.7M

Net Result (DKK)

About

Neumirna Therapeutics ApS is a anpartsselskab, operating in forskning og eksperimentel udvikling inden for naturvidenskab og teknik, based in København SV, Denmark, with 5 employees (2024). Founded in 2020.

Address

A.C. Meyers Vænge 15
2450 København SV

Management & Board

Financial Summary

YearRevenue/GPResultEquity
2024-5496k-8719k-18422k
2023-5476k-9745k-11468k
2022-4661k-6780k-3434k

Amounts in DKK. Source: Danish Business Authority (Erhvervsstyrelsen)

Get deeper insights via AI

Connect Dandex to Claude, ChatGPT, or Cursor for financial analysis, credit checks, network mapping, and more.

Data from the Danish Central Business Register (CVR) via Erhvervsstyrelsen. Last updated: 08/04/2026.